Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05653804

Impact of Tele-visit on Patients Continous Positive Airway Pressure (CPAP) Follow-up by Home Care Provider

Impact of Tele-visit Versus Home Visit by Home Care Provider on Compliance With Continuous Positive Airway Pressure (CPAP) Therapy of Patients With Obstructive Sleep Apnea Syndrome

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
320 (actual)
Sponsor
AGIR à Dom · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine the impact of telecare on continous positive airway pressure (CPAP) patients follow up by home care provider (HCP)

Detailed description

Obstructive sleep apnea (OSA) syndrome is a chronic respiratory pathology affecting 4% of french adult population and reference treatment for moderate to severe forms of obstructive sleep apnea syndrome (OSA) is continuous positive airway pressure (CPAP). However, CPAP treatment is binding, so nearly a quarter of patients abandoning treatment at 1 year and nearly half of them at 3 years. Support for these patients on CPAP must therefore be optimal and seek patient satisfaction; HCP (Home Care Provider) plays an important role in this follow-up. Since 2018 in France, teleconsultation entered on common law but was little used. The pandemic has disrupted the habits of care and patients monitoring by developing remote monitoring. Home Care Providers (HCP) have also been forced to organize remote monitoring, particularly for the annual follow-up visit (technical tele-visit). The impact of the annual follow-up visits of HCP by tele-visit has never been clinically evaluated. If its clinical relevance were demonstrated and patient satisfaction confirmed, this follow-up modality could become, like telecare, a new standard for the follow-up of patients on CPAP.

Conditions

Interventions

TypeNameDescription
PROCEDUREtele-visitThe remote visit content for CPAP follow up is based on home visit framework and carried out from a secure platform for sharing health data.

Timeline

Start date
2023-04-01
Primary completion
2026-05-11
Completion
2027-05-11
First posted
2022-12-16
Last updated
2026-02-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05653804. Inclusion in this directory is not an endorsement.